Lambda has been recognized as an NVIDIA Partner Network (NPN) 2025 Americas partner of the year award winner in the category of Healthcare, highlighting its work with customers and partners at the forefront of AI-driven innovation in healthcare and biotechnology. The company believes that AI can advance healthcare by analyzing vast amounts of data, identifying patterns, and uncovering insights that would be impossible for humans to achieve alone. By accelerating research and development, AI is helping researchers get closer to new treatments and cures. Lambda's role is to empower innovators by providing access to AI resources, including GPU cloud instances and clusters, ensuring seamless integration with NVIDIA accelerated computing and software. The company has worked tirelessly to enable enterprise-grade AI platforms for clinical applications and support breakthroughs in AI-discovered therapeutics, biomedicines, and drugs. Key partners, such as Genesis Therapeutics and Iambic, have praised Lambda's solutions, citing the scale and stability of their clusters accelerated by NVIDIA, which helped train large models like NeuralPlexer3. The recognition is a testament to collaboration and innovation in driving progress in healthcare.